condition found
Source: |
Type: |
Caspases are a cysteine protease that speed up a chemical reaction via pointing their target substrates following an aspartic acid residue.1 They are grouped into apoptotic (caspase-2, 3, 6, 7, 8, 9 and 10) and inflammatory (caspase-1, 4, 5, 11 and 12) mediated caspases. Caspase-1 may have both tumorigenic or antitumorigenic effects on cancer development and progression, but it depends on the type of inflammasome, methodology, and cancer. Catalase is an enzyme found in nearly all living cells exposed to oxygen. Its primary role is to protect cells from oxidative damage by catalyzing the conversion of hydrogen peroxide (H₂O₂), a potentially damaging byproduct of metabolism, into water (H₂O) and oxygen (O₂). This detoxification process is crucial because excess H₂O₂ can lead to the formation of reactive oxygen species (ROS) that damage proteins, lipids, and DNA. Catalase and Cancer Oxidative Stress and Cancer: Cancer cells often experience increased levels of oxidative stress due to rapid proliferation and metabolic changes. This stress can lead to DNA damage, promoting tumorigenesis. Catalase helps mitigate oxidative stress, and its expression can influence the survival and proliferation of cancer cells. Expression Levels in Different Cancers: Overexpression: In some cancers, such as breast cancer and certain types of leukemia, catalase may be overexpressed. This overexpression can help cancer cells survive in oxidative environments, potentially leading to more aggressive tumor behavior. Downregulation: Conversely, in other cancers, such as colorectal cancer, reduced catalase expression has been observed. This downregulation can lead to increased oxidative stress, contributing to tumor progression and metastasis. Prognostic Implications: Survival Rates: Studies have shown that high levels of catalase expression can be associated with poor prognosis in certain cancers, as it may enable cancer cells to resist apoptosis (programmed cell death) induced by oxidative stress. Some types of cancer cells have been reported to exhibit lower catalase activity, possibly increasing their vulnerability to oxidative damage under certain conditions. This vulnerability has even been exploited in some therapeutic strategies (for example, approaches that generate excess H₂O₂ or other ROS specifically targeting cancer cells have been researched). |
3453- | 5-ALA,  |   | The heme precursor 5-aminolevulinic acid disrupts the Warburg effect in tumor cells and induces caspase-dependent apoptosis |
- | in-vitro, | Lung, | A549 |
2558- | AL,  |   | Allicin, an Antioxidant and Neuroprotective Agent, Ameliorates Cognitive Impairment |
- | Review, | AD, | NA |
3439- | ALA,  |   | The effect of alpha lipoic acid on the developmental competence of mouse isolated preantral follicles |
- | in-vitro, | NA, | NA |
3545- | ALA,  |   | Potential therapeutic effects of alpha lipoic acid in memory disorders |
- | Review, | AD, | NA |
3269- | ALA,  |   | Sulfur-containing therapeutics in the treatment of Alzheimer’s disease |
- | NA, | AD, | NA |
3547- | ALA,  |   | Potential Therapeutic Effects of Lipoic Acid on Memory Deficits Related to Aging and Neurodegeneration |
- | Review, | AD, | NA | - | Review, | Park, | NA |
931- | And,  |   | Effect of Andrographis Paniculata Aqueous Extract on Hyperammonemia Induced Alteration of Oxidative and Nitrosative Stress Factors in the Liver, Spleen and Kidney of Rats |
- | in-vivo, | NA, | NA |
1146- | AP,  |   | Potential use of nanoformulated ascorbyl palmitate as a promising anticancer agent: First comparative assessment between nano and free forms |
- | in-vivo, | Nor, | NA |
2638- | Api,  |   | Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death |
- | in-vitro, | lymphoma, | PEL |
2317- | Api,  |   | Apigenin intervenes in liver fibrosis by regulating PKM2-HIF-1α mediated oxidative stress |
- | in-vivo, | Nor, | NA |
1547- | Api,  |   | Apigenin: Molecular Mechanisms and Therapeutic Potential against Cancer Spreading |
- | Review, | NA, | NA |
1562- | Api,  |   | Apigenin protects human melanocytes against oxidative damage by activation of the Nrf2 pathway |
- | in-vitro, | Vit, | NA |
3385- | ART/DHA,  |   | Interaction of artemisinin protects the activity of antioxidant enzyme catalase: A biophysical study |
- | Study, | NA, | NA |
3386- | ART/DHA,  |   | Effects of Caffeine-Artemisinin Combination on Liver Function and Oxidative Stress in Selected Organs in 7,12-Dimethylbenzanthracene-Treated Rats |
- | in-vivo, | Nor, | NA |
2294- | Ba,  |   | Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes |
- | in-vivo, | Nor, | NA |
2613- | Ba,  |   | Hepatoprotective Effect of Baicalein Against Acetaminophen-Induced Acute Liver Injury in Mice |
- | in-vivo, | Nor, | NA |
2674- | BBR,  |   | Berberine: A novel therapeutic strategy for cancer |
- | Review, | Var, | NA | - | Review, | IBD, | NA |
- | in-vivo, | Diabetic, | NA |
2760- | BetA,  |   | A Review on Preparation of Betulinic Acid and Its Biological Activities |
- | Review, | Var, | NA | - | Review, | Stroke, | NA |
2761- | BetA,  |   | Betulinic acid increases lifespan and stress resistance via insulin/IGF-1 signaling pathway in Caenorhabditis elegans |
- | in-vivo, | Nor, | NA |
2725- | BetA,  |   | Betulinic acid protects against renal damage by attenuation of oxidative stress and inflammation via Nrf2 signaling pathway in T-2 toxin-induced mice |
- | in-vivo, | Nor, | NA |
2731- | BetA,  |   | Betulinic Acid for Glioblastoma Treatment: Reality, Challenges and Perspectives |
- | Review, | GBM, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
726- | Bor,  |   | Redox Mechanisms Underlying the Cytostatic Effects of Boric Acid on Cancer Cells—An Issue Still Open |
- | Review, | NA, | NA |
729- | Bor,  |   | Promising potential of boron compounds against Glioblastoma: In Vitro antioxidant, anti-inflammatory and anticancer studies |
- | in-vitro, | GBM, | U87MG | - | in-vivo, | Nor, | HaCaT |
743- | Bor,  |   | Boric Acid (Boron) Attenuates AOM-Induced Colorectal Cancer in Rats by Augmentation of Apoptotic and Antioxidant Mechanisms |
- | in-vitro, | CRC, | NA |
696- | Bor,  |   | Nothing Boring About Boron |
- | Review, | Var, | NA |
3517- | Bor,  | Se,  |   | The protective effects of selenium and boron on cyclophosphamide-induced hepatic oxidative stress, inflammation, and apoptosis in rats |
- | in-vivo, | Nor, | NA |
3516- | Bor,  |   | Boron in wound healing: a comprehensive investigation of its diverse mechanisms |
- | Review, | Wounds, | NA |
3510- | Bor,  |   | Boron Affects the Development of the Kidney Through Modulation of Apoptosis, Antioxidant Capacity, and Nrf2 Pathway in the African Ostrich Chicks |
- | in-vivo, | Nor, | NA |
2776- | Bos,  |   | Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities |
- | Review, | Var, | NA |
2768- | Bos,  |   | Boswellic acids as promising agents for the management of brain diseases |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2014- | CAP,  |   | Role of Mitochondrial Electron Transport Chain Complexes in Capsaicin Mediated Oxidative Stress Leading to Apoptosis in Pancreatic Cancer Cells |
- | in-vitro, | PC, | Bxpc-3 | - | in-vitro, | Nor, | HPDE-6 | - | in-vivo, | PC, | AsPC-1 |
2652- | CAP,  |   | Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence |
- | Review, | Var, | NA |
2653- | Cela,  |   | Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence |
- | Review, | Var, | NA |
2794- | CHr,  |   | An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches |
- | Review, | Park, | NA | - | Review, | Stroke, | NA |
2796- | CHr,  |   | Chemopreventive effect of chrysin, a dietary flavone against benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice |
- | in-vivo, | Lung, | NA |
2781- | CHr,  | PBG,  |   | Chrysin a promising anticancer agent: recent perspectives |
- | Review, | Var, | NA |
2807- | CHr,  |   | Evidence-based mechanistic role of chrysin towards protection of cardiac hypertrophy and fibrosis in rats |
- | in-vivo, | Nor, | NA |
2784- | CHr,  |   | Chrysin targets aberrant molecular signatures and pathways in carcinogenesis (Review) |
- | Review, | Var, | NA |
1570- | Cu,  |   | Development of copper nanoparticles and their prospective uses as antioxidants, antimicrobials, anticancer agents in the pharmaceutical sector |
- | Review, | NA, | NA |
2819- | CUR,  | Chemo,  |   | Curcumin as a hepatoprotective agent against chemotherapy-induced liver injury |
- | Review, | Var, | NA |
- | Review, | AD, | NA |
2810- | CUR,  |   | Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials |
- | Review, | Nor, | NA |
2654- | CUR,  |   | Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence |
- | Review, | Var, | NA |
20- | EGCG,  |   | Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer |
- | in-vivo, | Liver, | NA | - | in-vivo, | Tong, | NA |
1974- | EGCG,  |   | Protective Effect of Epigallocatechin-3-Gallate in Hydrogen Peroxide-Induced Oxidative Damage in Chicken Lymphocytes |
- | in-vitro, | Nor, | NA |
3210- | EGCG,  |   | Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells |
- | in-vitro, | Nor, | NA |
3222- | EGCG,  |   | Epigallocatechin gallate and mitochondria—A story of life and death |
- | Review, | Nor, | NA |
1656- | FA,  |   | Ferulic Acid: A Natural Phenol That Inhibits Neoplastic Events through Modulation of Oncogenic Signaling |
- | Review, | Var, | NA |
2861- | FIS,  |   | The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress |
- | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
2862- | FIS,  |   | Fisetin averts oxidative stress in pancreatic tissues of streptozotocin-induced diabetic rat |
- | in-vivo, | Diabetic, | NA |
1407- | GoldNP,  | Z,  |   | The antioxidant effects of silver, gold, and zinc oxide nanoparticles on male mice in in vivo condition |
- | in-vivo, | NA, | NA |
834- | Gra,  |   | Anticancer Properties of Graviola (Annona muricata): A Comprehensive Mechanistic Review |
- | Review, | NA, | NA |
2508- | H2,  |   | Molecular hydrogen is a promising therapeutic agent for pulmonary disease |
- | Review, | Var, | NA | - | Review, | Sepsis, | NA |
2521- | H2,  |   | Oxyhydrogen Gas: A Promising Therapeutic Approach for Lung, Breast and Colorectal Cancer |
- | Review, | CRC, | NA | - | Review, | Lung, | NA | - | Review, | BC, | NA |
1635- | HCA,  |   | Hydroxycitric acid prevents hyperoxaluric-induced nephrolithiasis and oxidative stress via activation of the Nrf2/Keap1 signaling pathway |
- | vitro+vivo, | Nor, | NA |
1637- | HCA,  | OLST,  |   | Orlistat and Hydroxycitrate Ameliorate Colon Cancer in Rats: The Impact of Inflammatory Mediators |
- | in-vivo, | Colon, | NA |
1638- | HCAs,  |   | Anticancer potential of hydroxycinnamic acids: mechanisms, bioavailability, and therapeutic applications |
- | Review, | Nor, | NA |
2868- | HNK,  |   | Honokiol: A review of its pharmacological potential and therapeutic insights |
- | Review, | Var, | NA | - | Review, | Sepsis, | NA |
2869- | HNK,  |   | Nature's neuroprotector: Honokiol and its promise for Alzheimer's and Parkinson's |
- | Review, | AD, | NA | - | Review, | Park, | NA |
986- | LT,  | doxoR,  |   | Luteolin as a glycolysis inhibitor offers superior efficacy and lesser toxicity of doxorubicin in breast cancer cells |
- | in-vitro, | BC, | 4T1 | - | in-vitro, | BC, | MCF-7 |
2915- | LT,  |   | Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells |
- | in-vitro, | Colon, | HT29 | - | in-vitro, | CRC, | SNU-407 | - | in-vitro, | Nor, | FHC |
2916- | LT,  |   | Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2919- | LT,  |   | Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence |
- | Review, | Var, | NA |
2904- | LT,  |   | Luteolin from Purple Perilla mitigates ROS insult particularly in primary neurons |
- | in-vitro, | Park, | SK-N-SH | - | in-vitro, | AD, | NA |
2906- | LT,  |   | Luteolin, a flavonoid with potentials for cancer prevention and therapy |
- | Review, | Var, | NA |
2907- | LT,  |   | Protective effect of luteolin against oxidative stress‑mediated cell injury via enhancing antioxidant systems |
- | in-vitro, | Nor, | NA |
1709- | Lyco,  |   | Lycopene prevents carcinogen-induced cutaneous tumor by enhancing activation of the Nrf2 pathway through p62-triggered autophagic Keap1 degradation |
- | in-vitro, | Nor, | JB6 |
1708- | Lyco,  |   | The Anti-Cancer Activity of Lycopene: A Systematic Review of Human and Animal Studies |
- | Review, | Var, | NA |
3277- | Lyco,  |   | Recent trends and advances in the epidemiology, synergism, and delivery system of lycopene as an anti-cancer agent |
- | Review, | Var, | NA |
3268- | Lyco,  |   | Lycopene as a Natural Antioxidant Used to Prevent Human Health Disorders |
- | Review, | AD, | NA |
3264- | Lyco,  |   | Pharmacological potentials of lycopene against aging and aging‐related disorders: A review |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
3261- | Lyco,  |   | Lycopene and Vascular Health |
- | Review, | Stroke, | NA |
1782- | MEL,  |   | Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities |
- | Review, | Var, | NA |
1779- | MEL,  |   | Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review |
- | Review, | BC, | NA |
1204- | MET,  |   | Metformin induces ferroptosis through the Nrf2/HO-1 signaling in lung cancer |
- | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H1299 |
2253- | MF,  |   | Low-frequency pulsed electromagnetic field promotes functional recovery, reduces inflammation and oxidative stress, and enhances HSP70 expression following spinal cord injury |
- | in-vivo, | Nor, | NA |
3498- | MF,  |   | Effect of Static Magnetic Field on Oxidant/Antioxidant Parameters in Cancerous and Noncancerous Human Gastric Tissues |
- | in-vitro, | GC, | NA |
3484- | MF,  |   | Extremely low frequency pulsed electromagnetic fields cause antioxidative defense mechanisms in human osteoblasts via induction of •O2 − and H2O2 |
- | in-vitro, | Nor, | NA |
3457- | MF,  |   | Cellular stress response to extremely low‐frequency electromagnetic fields (ELF‐EMF): An explanation for controversial effects of ELF‐EMF on apoptosis |
- | Review, | Var, | NA |
209- | MFrot,  |   | The effect of a rotating magnetic field on the antioxidant system in healthy volunteers - preliminary study |
- | Human, | NA, | NA |
3567- | MFrot,  |   | The Effect of Extremely Low-Frequency Magnetic Field on Stroke Patients: A Systematic Review |
- | Review, | Stroke, | NA |
946- | Nimb,  |   | Nimbolide retards T cell lymphoma progression by altering apoptosis, glucose metabolism, pH regulation, and ROS homeostasis |
- | in-vivo, | NA, | NA |
1987- | Part,  | Rad,  |   | A NADPH oxidase dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells |
- | in-vitro, | Pca, | PC3 | - | in-vitro, | Nor, | PrEC |
3250- | PBG,  |   | Allergic Inflammation: Effect of Propolis and Its Flavonoids |
- | Review, | NA, | NA |
3251- | PBG,  |   | The Antioxidant and Anti-Inflammatory Effects of Flavonoids from Propolis via Nrf2 and NF-κB Pathways |
- | Review, | AD, | NA | - | Review, | Diabetic, | NA | - | Review, | Var, | NA | - | in-vitro, | Nor, | H9c2 |
3257- | PBG,  |   | The Potential Use of Propolis as a Primary or an Adjunctive Therapy in Respiratory Tract-Related Diseases and Disorders: A Systematic Scoping Review |
- | Review, | Var, | NA |
3259- | PBG,  |   | Propolis and its therapeutic effects on renal diseases: A review |
- | Review, | Nor, | NA |
1767- | PG,  |   | Propyl gallate induces cell death in human pulmonary fibroblast through increasing reactive oxygen species levels and depleting glutathione |
- | in-vitro, | Nor, | NA |
2969- | PL,  |   | Piperlongumine induces autophagy by targeting p38 signaling |
- | in-vitro, | OS, | U2OS | - | in-vitro, | Cerv, | HeLa |
1942- | PL,  |   | Piperlongumine inhibits antioxidant enzymes, increases ROS levels, induces DNA damage and G2/M cell cycle arrest in breast cell lines |
- | in-vitro, | BC, | MCF-7 |
79- | QC,  |   | Chemopreventive Effect of Quercetin in MNU and Testosterone Induced Prostate Cancer of Sprague-Dawley Rats |
- | in-vivo, | Pca, | NA |
39- | QC,  |   | A Comprehensive Analysis and Anti-Cancer Activities of Quercetin in ROS-Mediated Cancer and Cancer Stem Cells |
- | Analysis, | NA, | NA |
2343- | QC,  |   | Pharmacological Activity of Quercetin: An Updated Review |
- | Review, | Nor, | NA |
- | in-vivo, | Sepsis, | NA |
3343- | QC,  |   | Quercetin, a Flavonoid with Great Pharmacological Capacity |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Arthritis, | NA |
3341- | QC,  |   | Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application |
- | Review, | Var, | NA | - | Review, | Stroke, | NA |
3338- | QC,  |   | Quercetin: Its Antioxidant Mechanism, Antibacterial Properties and Potential Application in Prevention and Control of Toxipathy |
- | Review, | Var, | NA | - | Review, | Stroke, | NA |
2443- | RES,  |   | Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review |
- | Review, | Var, | NA |
3068- | RES,  |   | Resveratrol decreases the expression of genes involved in inflammation through transcriptional regulation |
- | in-vitro, | lymphoma, | U937 |
3079- | RES,  |   | Therapeutic role of resveratrol against hepatocellular carcinoma: A review on its molecular mechanisms of action |
- | Review, | Var, | NA |
3057- | RES,  |   | The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
3024- | RosA,  |   | rmMANF prevents sepsis-associated lung injury via inhibiting endoplasmic reticulum stress-induced ferroptosis in mice |
- | in-vivo, | Sepsis, | NA |
3014- | RosA,  |   | Rosmarinic Acid Supplementation Acts as an Effective Antioxidant for Restoring the Antioxidation/Oxidation Balance in Wistar Rats with Cadmium-Induced Toxicity |
- | in-vivo, | Nor, | NA |
3001- | RosA,  |   | Therapeutic Potential of Rosmarinic Acid: A Comprehensive Review |
- | Review, | Var, | NA |
1749- | RosA,  |   | Rosmarinic Acid and Related Dietary Supplements: Potential Applications in the Prevention and Treatment of Cancer |
- | Review, | Var, | NA |
1748- | RosA,  |   | The Role of Rosmarinic Acid in Cancer Prevention and Therapy: Mechanisms of Antioxidant and Anticancer Activity |
- | Review, | Var, | NA |
323- | Sal,  | SNP,  |   | Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy |
- | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Ovarian, | A2780S |
984- | Sel,  |   | Effects of selenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells |
- | in-vitro, | BC, | MCF-7 |
2553- | SFN,  |   | Mechanistic review of sulforaphane as a chemoprotective agent in bladder cancer |
- | Review, | Bladder, | NA |
3184- | SFN,  |   | The Integrative Role of Sulforaphane in Preventing Inflammation, Oxidative Stress and Fatigue: A Review of a Potential Protective Phytochemical |
- | Review, | Nor, | NA |
2444- | SFN,  |   | Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage |
- | in-vitro, | Nor, | MRC-5 |
3307- | SIL,  |   | Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications |
- | Review, | Var, | NA |
3310- | SIL,  |   | Silymarin attenuates paraquat-induced lung injury via Nrf2-mediated pathway in vivo and in vitro |
- | in-vitro, | Lung, | A549 |
3300- | SIL,  |   | Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy |
- | Review, | Var, | NA |
3315- | SIL,  |   | Silymarin alleviates docetaxel-induced central and peripheral neurotoxicity by reducing oxidative stress, inflammation and apoptosis in rats |
- | in-vivo, | Nor, | NA |
3319- | SIL,  |   | Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
3318- | SIL,  |   | Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3040- | SK,  |   | Pharmacological Properties of Shikonin – A Review of Literature since 2002 |
- | Review, | Var, | NA | - | Review, | IBD, | NA | - | Review, | Stroke, | NA |
1345- | SK,  |   | The Critical Role of Redox Homeostasis in Shikonin-Induced HL-60 Cell Differentiation via Unique Modulation of the Nrf2/ARE Pathway |
- | in-vitro, | AML, | HL-60 |
1344- | SK,  |   | Novel multiple apoptotic mechanism of shikonin in human glioma cells |
- | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | Hs683 | - | in-vitro, | GBM, | M059K |
2205- | SNP,  |   | Potential protective efficacy of biogenic silver nanoparticles synthesised from earthworm extract in a septic mice model |
- | in-vivo, | Nor, | NA |
- | in-vivo, | Nor, | NA |
1406- | SNP,  |   | The antioxidant effects of silver, gold, and zinc oxide nanoparticles on male mice in in vivo condition |
- | in-vivo, | Nor, | NA |
335- | SNP,  | PDT,  |   | Biogenic Silver Nanoparticles for Targeted Cancer Therapy and Enhancing Photodynamic Therapy |
- | Review, | NA, | NA |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | Bladder, | HTB-22 |
1937- | TQ,  |   | Migration and Proliferation Effects of Thymoquinone-Loaded Nanostructured Lipid Carrier (TQ-NLC) and Thymoquinone (TQ) on In Vitro Wound Healing Models |
- | NA, | Nor, | 3T3 |
2121- | TQ,  |   | Thymoquinone Inhibits Tumor Growth and Induces Apoptosis in a Breast Cancer Xenograft Mouse Model: The Role of p38 MAPK and ROS |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
2092- | TQ,  |   | Dissecting the Potential Roles of Nigella sativa and Its Constituent Thymoquinone on the Prevention and on the Progression of Alzheimer's Disease |
- | Review, | AD, | NA |
2106- | TQ,  |   | Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy |
- | Review, | Var, | NA |
- | in-vitro, | Nor, | SH-SY5Y |
2088- | TQ,  |   | Nigella sativa L. and Its Bioactive Constituents as Hepatoprotectant: A Review |
- | Review, | Nor, | NA |
2087- | TQ,  |   | Nigella sativa thymoquinone-rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats |
- | in-vivo, | Nor, | NA |
2086- | TQ,  |   | Cardioprotective effects of Nigella sativa oil on cyclosporine A-induced cardiotoxicity in rats |
- | in-vivo, | Nor, | NA |
3422- | TQ,  |   | Thymoquinone, as a Novel Therapeutic Candidate of Cancers |
- | Review, | Var, | NA |
3400- | TQ,  | Chemo,  |   | Thymoquinone Ameliorates Carfilzomib-Induced Renal Impairment by Modulating Oxidative Stress Markers, Inflammatory/Apoptotic Mediators, and Augmenting Nrf2 in Rats |
- | in-vitro, | Nor, | NA |
3399- | TQ,  |   | Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD-L1 in Triple-Negative Breast Cancer Cells |
- | in-vitro, | BC, | MDA-MB-231 | - | NA, | BC, | MDA-MB-468 |
3398- | TQ,  | 5-FU,  |   | Impact of thymoquinone on the Nrf2/HO-1 and MAPK/NF-κB axis in mitigating 5-fluorouracil-induced acute kidney injury in vivo |
- | in-vivo, | Nor, | NA |
3397- | TQ,  |   | Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer |
- | Review, | CRC, | NA |
3410- | TQ,  |   | Anti-inflammatory effects of thymoquinone and its protective effects against several diseases |
- | Review, | Arthritis, | NA |
3404- | TQ,  |   | The Neuroprotective Effects of Thymoquinone: A Review |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
3559- | TQ,  |   | Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease |
- | Review, | AD, | NA | - | Review, | Var, | NA |
2411- | UA,  |   | Ursolic acid in health and disease |
- | Review, | Var, | NA |
3112- | VitC,  |   | Antioxidative and Anti-Inflammatory Activity of Ascorbic Acid |
- | Review, | Nor, | NA |
3110- | VitC,  |   | Vitamin C Attenuates Oxidative Stress, Inflammation, and Apoptosis Induced by Acute Hypoxia through the Nrf2/Keap1 Signaling Pathway in Gibel Carp (Carassius gibelio) |
- | in-vivo, | Nor, | NA |
618- | VitC,  |   | Low levels of catalase enzyme make cancer cells vulnerable to high-dose ascorbate |
619- | VitC,  |   | Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:46 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid